MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,488,367 | -30.4% | 797,553 | +2.4% | 0.00% | -100.0% |
| Q2 2023 | $3,573,912 | -5.2% | 778,630 | +2.3% | 0.00% | 0.0% |
| Q1 2023 | $3,768,652 | -8.5% | 761,344 | +0.9% | 0.00% | 0.0% |
| Q4 2022 | $4,118,112 | -15.8% | 754,233 | +0.3% | 0.00% | 0.0% |
| Q3 2022 | $4,890,000 | +68.6% | 752,351 | +22.7% | 0.00% | 0.0% |
| Q2 2022 | $2,900,000 | -42.2% | 613,139 | -14.5% | 0.00% | 0.0% |
| Q1 2022 | $5,013,000 | -29.9% | 717,257 | +2.2% | 0.00% | 0.0% |
| Q4 2021 | $7,152,000 | +419.4% | 701,907 | +522.3% | 0.00% | – |
| Q3 2021 | $1,377,000 | – | 112,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
| Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
| NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
| Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
| RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
| Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
| Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
| First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
| Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
| Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |